Vaxart VXRT Stock
Vaxart Price Chart
Vaxart VXRT Financial and Trading Overview
| Vaxart stock price | 0.4 USD |
| Previous Close | 0.87 USD |
| Open | 0.87 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1200 |
| Day's Range | 0.84 - 0.88 USD |
| 52 Week Range | 0.56 - 4.62 USD |
| Volume | 1.62M USD |
| Avg. Volume | 1.84M USD |
| Market Cap | 132.21M USD |
| Beta (5Y Monthly) | 0.784507 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | November 9, 2012 |
| 1y Target Est | 6.13 USD |
VXRT Valuation Measures
| Enterprise Value | 69.84M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3626562 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 189.6811 |
| Price/Book (mrq) | 1.3173716 |
| Enterprise Value/Revenue | 100.207 |
| Enterprise Value/EBITDA | -0.669 |
Trading Information
Vaxart Stock Price History
| Beta (5Y Monthly) | 0.784507 |
| 52-Week Change | -72.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.62 USD |
| 52 Week Low | 0.56 USD |
| 50-Day Moving Average | 0.96 USD |
| 200-Day Moving Average | 1.28 USD |
VXRT Share Statistics
| Avg. Volume (3 month) | 1.84M USD |
| Avg. Daily Volume (10-Days) | 3.53M USD |
| Shares Outstanding | 151.6M |
| Float | 134.82M |
| Short Ratio | 9.84 |
| % Held by Insiders | 1.69% |
| % Held by Institutions | 33.20% |
| Shares Short | 20.95M |
| Short % of Float | 15.55% |
| Short % of Shares Outstanding | 15.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:11 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -15943.90% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.064% |
| Return on Equity (ttm) | -84.17% |
Income Statement
| Revenue (ttm) | 697K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | 694.10% |
| Gross Profit (ttm) | -80947000 USD |
| EBITDA | -104393000 USD |
| Net Income Avi to Common (ttm) | -107797000 USD |
| Diluted EPS (ttm) | -0.81 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 70.21M USD |
| Total Cash Per Share (mrq) | 0.52 USD |
| Total Debt (mrq) | 21.52M USD |
| Total Debt/Equity (mrq) | 23.97 USD |
| Current Ratio (mrq) | 4.835 |
| Book Value Per Share (mrq) | 0.662 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -94126000 USD |
| Levered Free Cash Flow (ttm) | -55538000 USD |
Profile of Vaxart
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 170 Harbor Way |
| ZIP | 94080 |
| Phone | 650 550 3500 |
| Website | https://vaxart.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 164 |
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Q&A For Vaxart Stock
What is a current VXRT stock price?
Vaxart VXRT stock price today per share is 0.4 USD.
How to purchase Vaxart stock?
You can buy VXRT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vaxart?
The stock symbol or ticker of Vaxart is VXRT.
Which industry does the Vaxart company belong to?
The Vaxart industry is Biotechnology.
How many shares does Vaxart have in circulation?
The max supply of Vaxart shares is 228.21M.
What is Vaxart Price to Earnings Ratio (PE Ratio)?
Vaxart PE Ratio is now.
What was Vaxart earnings per share over the trailing 12 months (TTM)?
Vaxart EPS is -0.33 USD over the trailing 12 months.
Which sector does the Vaxart company belong to?
The Vaxart sector is Healthcare.
Vaxart VXRT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}